Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
HealthCare Global Enterprises Limited (HCG.NS)
Bengaluru, IN
HealthCare Global Enterprises Limited, founded in 1989 and headquartered in Bengaluru, India, delivers comprehensive healthcare services with a primary focus on oncology. The company offers a full spectrum of cancer care, from diagnosis to various treatment modalities such as radiation therapy, medical oncology, and surgical procedures. Beyond its core cancer services, HCG also operates in the field of fertility and reproductive medicine under its Milann brand. This includes services like assisted reproduction, gynecological endoscopy, and fertility preservation. The enterprise further manages four multi-specialty hospitals: three branded HCG facilities located in Ahmedabad, Bhavnagar, and Rajkot in Gujarat, and one in Hubli, Karnataka, operated under a management contract. These hospitals cater to diverse medical specialities including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonary care, and critical care. Additionally, HealthCare Global provides medical diagnostic services, offering scientific testing and consultancy for the pharmaceutical and broader medical industries. As of March 31, 2021, its extensive network comprised 23 cancer centers throughout India, featuring a center of excellence in Bengaluru, alongside two independent diagnostic centers and one day-care chemotherapy unit. The company also maintains an international presence with a cancer center established in Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.84% | +1.94% | +9.10% | +7.16% | -13.39% | -5.29% | +3.41% | +100.13% | +232.36% | +248.24% | +251.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 8 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+14.2% ★ Q1'26: +11.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-69.4% Q1'26: -71.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-0.8% Q1'26: +5.2% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+8.0% Q1'26: +6.8% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+6.6% Q1'26: +6.8% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+1.3% Q1'26: +2.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.88× Q1'26: 4.06× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 9 Rev. Ana. 7 EPS Ana. |
Mar 2027 9 Rev. Ana. 8 EPS Ana. |
Mar 2028 9 Rev. Ana. 8 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.84B
est: 5.73B (+1.9%)
|
7.00B
est: 7.00B (+0.0%)
|
8.31B
est: 8.35B (-0.5%)
|
9.79B
est: 9.79B (0.0%)
|
10.96B
est: 11.10B (-1.3%)
|
10.13B
est: 10.02B (+1.2%)
|
13.98B
est: 13.97B (+0.0%)
|
16.94B
est: 16.88B (+0.4%)
|
19.12B
est: 19.77B (-3.3%)
|
22.23B
est: 22.36B (-0.6%)
|
25.47B
24.96B – 25.78B
+13.9% YoY
|
29.57B
28.87B – 30.58B
+16.1% YoY
|
33.98B
32.95B – 35.15B
+14.9% YoY
|
| EBITDA |
837.72M
est: 702.62M (+19.2%)
|
1.04B
est: 90.56M (+1,048.7%)
|
1.16B
est: 915.91M (+26.9%)
|
1.21B
est: 814.17M (+49.2%)
|
1.21B
est: -149.53M (+908.7%)
|
656.22M
est: -952.54M (+168.9%)
|
1.78B
est: -1.17B (+252.0%)
|
2.37B
est: -1.34B (+277.2%)
|
2.67B
est: 4.27B (-37.5%)
|
3.13B
est: 4.84B (-35.4%)
|
5.50B
5.39B – 5.57B
+13.7% YoY
|
6.39B
6.24B – 6.61B
+16.1% YoY
|
7.34B
7.12B – 7.60B
+14.9% YoY
|
| EBIT |
406.70M
est: 304.18M (+33.7%)
|
478.78M
est: 429.73M (+11.4%)
|
469.50M
est: 562.65M (-16.6%)
|
396.09M
est: 687.24M (-42.4%)
|
229.47M
est: 427.61M (-46.3%)
|
-333.74M
est: 190.80M (-274.9%)
|
795.46M
est: 235.14M (+238.3%)
|
1.36B
est: 268.23M (+405.3%)
|
1.55B
est: 3.78B (-58.9%)
|
1.78B
est: 4.29B (-58.5%)
|
4.87B
4.78B – 4.93B
+13.7% YoY
|
5.66B
5.52B – 5.85B
+16.1% YoY
|
6.50B
6.30B – 6.73B
+14.9% YoY
|
| Net Income |
-14.61M
est: 63.64M (-123.0%)
|
221.73M
est: -18.01M (+1,331.3%)
|
205.23M
est: 258.67M (-20.7%)
|
-247.97M
est: 242.47M (-202.3%)
|
-1.07B
est: -282.44M (-277.8%)
|
-1.93B
est: -996.08M (-94.2%)
|
537.33M
est: -1.23B (+143.8%)
|
293.49M
est: 309.00M (-5.0%)
|
481.55M
est: 526.10M (-8.5%)
|
444.10M
est: 493.56M (-10.0%)
|
505.31M
327.39M – 1.07B
+2.4% YoY
|
1.35B
950.25M – 2.33B
+167.4% YoY
|
2.22B
1.55B – 3.23B
+64.0% YoY
|
| SGA |
319.85M
est: 175.85M (+81.9%)
|
439.50M
est: 2.48B (-82.3%)
|
623.29M
est: 2.89B (-78.4%)
|
685.16M
est: 3.76B (-81.8%)
|
289.18M
est: 4.39B (-93.4%)
|
189.58M
est: 4.00B (-95.3%)
|
273.86M
est: 4.93B (-94.4%)
|
765.17M
est: 5.63B (-86.4%)
|
623.96M
est: 606.53M (+2.9%)
|
829.29M
est: 687.37M (+20.6%)
|
781.31M
765.87M – 790.93M
+13.7% YoY
|
907.16M
885.64M – 938.08M
+16.1% YoY
|
1.04B
1.01B – 1.08B
+14.9% YoY
|
| EPS |
-2.44
est: 0.45 (-642.2%)
|
2.70
est: 2.63 (+2.5%)
|
2.39
est: 1.72 (+39.0%)
|
-2.82
est: -2.87 (+1.6%)
|
-12.05
est: -6.38 (-88.8%)
|
-17.02
est: -8.38 (-103.1%)
|
4.14
est: -0.92 (+550.0%)
|
2.11
est: 2.13 (-1.1%)
|
3.46
est: 3.78 (-8.4%)
|
3.19
est: 3.47 (-8.2%)
|
3.96
2.31 – 7.55
+14.1% YoY
|
11.51
6.72 – 16.49
+190.5% YoY
|
18.71
10.93 – 22.81
+62.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | B- | 2/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.03% | 194.3K | 0.65% |
| 2 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 22.8K | 0.56% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 302.8K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 279.1K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 126.0K | 0.28% |
| 6 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 908.34 | 0.44% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sunu Manuel | Compliance Officer & Company Secretary | 6M | female |
| Ashutosh Kumar | Vice President of Strategic Planning & Corporate Development | — | male |
| Deepti Gautam Tewari | Chief Human Resource Officer | — | female |
| Lakshman | Chief Executive Officer of Milann Fertility & Birthing Hospitals | — | male |
| Manish Mattoo | CEO, Interim CFO & Executive Director | — | — |
| Manisha Kumar | Cluster Head & Chief Operating Officer | — | — |
| Manu Shankar Das | Chief Marketing Officer | — | male |
| Naveen Ramachandra Nagar | Head of Clinical Strategy | — | — |
| Pankaj Gautam | Chief Technology & Security Officer and Chief Information Officer | — | male |
| Romiya Das | Public Relation Manager | — | — |
| Shailesh Guntu | Chief Executive Officer of Milann & Director of Healthcare Services-HCG | — | — |
| Surinder Dang | Chief Operating Officer of Regional | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HCG.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
